Stock is currently trading at a 40% discount to its fair value estimate. There’s consensus that Pfizer will continue steady growth and it definitely offers high trailing yield. The only downside is that patent losses will likely increase after 2028, but Pfizer is a robust company with a competitive advantage in developing new dr-gs. I’m considering buying, especially given a discount value, as I’m looking for a long-term investment. Any reason to stay away?
There are no replies in this thread yet. Be the first to post a reply below: